Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?

Abstract

This paper encourages understanding a non-invasive technology—the “Liquid biopsy”, including circulating tumor cells (CTCs) and circulating tumor DNA (ct DNA) technology, that can help diagnose early cancers, cancer relapse, and resistance to chemotherapy. This paper reviews various CTCs and ct DNA studies in the literature about their applications in gynecological cancers. Hopefully, further translational cancer research in gynecology will enable personalized cancer treatment to become a realistic expectation.

Keywords

• gynecological cancers
• liquid biopsy
• circulating tumor cells
• circulating tumor dna